Late Renal Effects of COVID-19 in Kidney Transplant Recipients: A Single-Center Study
Main Author: | |
---|---|
Publication Date: | 2025 |
Other Authors: | , , , |
Format: | Article |
Language: | eng por |
Source: | Brazilian Journal of Transplantation |
Download full: | https://bjt.emnuvens.com.br/revista/article/view/654 |
Summary: | Introduction: During the coronavirus disease 2019 (COVID-19) pandemic, kidney transplant recipients had higher rates of hospitalization and mortality. However, data on the late renal effects of the infection are scarce. Objectives: This study aims to describe the evolution of renal function and proteinuria in kidney transplant recipients after the infection. Methods: Single-center prospective cohort study. A total of 321 kidney transplant recipients who survived COVID-19 from March 2020 to December 2022 were included. Data on renal function, proteinuria, and immunosuppression were analyzed pre-infection, 3 and 6 months post-infection. Results: Most patients were male (58.9%), with a mean age of 50 years, recipients of kidneys from deceased donors (79.4%), and with a median time after transplant of 6.6 years. There was a reduction in the level of immunosuppression, from a pre-infection Vasudev score of 4.66 to 4.50 (p< 0.001) in the 3rd month and 4.54 (p = 0.016) 6 months post-infection. The glomerular filtration rate (GFR) remained stable at around 60 mL/min/1.73 m2. The percentage of patients with proteinuria ≥ 1.0 increased from 9.6% pre-infection to more than 13% (p < 0.001) in the 3rd and 6th months after infection. Higher proteinuria levels were observed in recipients with longer follow-up post-transplant, previous rejection episodes, lower estimated GFR, and higher prevalence of donor-specific anti-HLA antibodies. Conclusions: Kidney transplant recipients with COVID-19 had an increase in proteinuria within 6 months after the infection despite a stable GFR. |
id |
ABTO_10e02b0a6d259a01fbea9915c0f22d38 |
---|---|
oai_identifier_str |
oai:ojs3.emnuvens.com.br:article/654 |
network_acronym_str |
ABTO |
network_name_str |
Brazilian Journal of Transplantation |
repository_id_str |
|
spelling |
Late Renal Effects of COVID-19 in Kidney Transplant Recipients: A Single-Center StudyEfeitos Renais Tardios de COVID-19 em Receptores de Transplante Renal: Estudo UnicêntricoTransplante de RimCOVID-19SARS-CoV-2Síndrome de COVID-19 Pós-AgudaProteinúriaKidney transplantationCOVID-19SARS-CoV-2Post-Acute COVID-19 SyndromeProteinuriaIntroduction: During the coronavirus disease 2019 (COVID-19) pandemic, kidney transplant recipients had higher rates of hospitalization and mortality. However, data on the late renal effects of the infection are scarce. Objectives: This study aims to describe the evolution of renal function and proteinuria in kidney transplant recipients after the infection. Methods: Single-center prospective cohort study. A total of 321 kidney transplant recipients who survived COVID-19 from March 2020 to December 2022 were included. Data on renal function, proteinuria, and immunosuppression were analyzed pre-infection, 3 and 6 months post-infection. Results: Most patients were male (58.9%), with a mean age of 50 years, recipients of kidneys from deceased donors (79.4%), and with a median time after transplant of 6.6 years. There was a reduction in the level of immunosuppression, from a pre-infection Vasudev score of 4.66 to 4.50 (p< 0.001) in the 3rd month and 4.54 (p = 0.016) 6 months post-infection. The glomerular filtration rate (GFR) remained stable at around 60 mL/min/1.73 m2. The percentage of patients with proteinuria ≥ 1.0 increased from 9.6% pre-infection to more than 13% (p < 0.001) in the 3rd and 6th months after infection. Higher proteinuria levels were observed in recipients with longer follow-up post-transplant, previous rejection episodes, lower estimated GFR, and higher prevalence of donor-specific anti-HLA antibodies. Conclusions: Kidney transplant recipients with COVID-19 had an increase in proteinuria within 6 months after the infection despite a stable GFR.Introdução: Durante a pandemia causada pela doença do coronavírus 2019 (COVID-19), os receptores de transplante renal apresentaram maiores taxas de hospitalização e mortalidade. No entanto, os dados sobre os efeitos renais tardios da infecção são escassos. Objetivos: Este estudo tem como objetivo descrever a evolução da função renal e proteinúria em receptores de transplante renal após a infecção. Métodos: Estudo de coorte prospectivo unicêntrico. O total de 321 receptores de transplante renal que sobreviveram à COVID-19 de março de 2020 a dezembro de 2022 foi incluído. Dados sobre função renal, proteinúria e imunossupressão foram analisados pré-infecção, 3 e 6 meses após a infecção. Resultados: A maioria dos pacientes era do sexo masculino (58,9%), com média de idade de 50 anos, receptor de rins de doadores falecidos (79,4%) e com mediana de tempo pós-transplante de 6,6 anos. Houve redução do nível de imunossupressão, de um escore de Vasudev pré-infecção de 4,66 para 4,50 (p < 0,001) no 3º mês e 4,54 (p = 0,016) 6 meses pós-infecção. A taxa de filtração glomerular (TFG) permaneceu estável, em torno de 60 mL/min/1,73 m2. A porcentagem de pacientes com proteinúria ≥ 1,0 aumentou de 9,6% pré-infecção para mais de 13% (p < 0,001) nos 3º e 6º meses após a infecção. Níveis mais elevados de proteinúria foram observados em receptores com maior tempo de seguimento pós-transplante, episódios de rejeição prévios, menor TFG estimada e maior prevalência de anticorpos anti-HLA doador-específicos. Conclusão: Os receptores de transplante renal com COVID-19 tiveram um aumento na proteinúria em 6 meses após a infecção, apesar de apresentarem TFG estável. Associação Brasileira de Transplante de Órgãos (ABTO)2025-02-14info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfapplication/pdfhttps://bjt.emnuvens.com.br/revista/article/view/654Brazilian Journal of Transplantation; Vol. 28 (2025)Brazilian Journal of Transplantation; v. 28 (2025)2764-1589reponame:Brazilian Journal of Transplantationinstname:Associação Brasileira de Transplante de Órgãos (ABTO)instacron:ABTOengporhttps://bjt.emnuvens.com.br/revista/article/view/654/727https://bjt.emnuvens.com.br/revista/article/view/654/728Copyright (c) 2025 Bruno Teixeira Gomes, Marcos Vinicius de Sousa, Fernanda Garcia Bressanin, Matheus Rizzato Rossi, Marilda Mazzaliinfo:eu-repo/semantics/openAccessGomes, Bruno Teixeira Sousa, Marcos Vinicius deBressanin, Fernanda Garcia Rossi, Matheus RizzatoMazzali, Marilda2025-02-14T12:55:38Zoai:ojs3.emnuvens.com.br:article/654Revistahttps://bjt.emnuvens.com.br/revistaONGhttps://bjt.emnuvens.com.br/revista/oaibjt@abto.org.brhttps://doi.org/10.53855/2764-15892764-1589opendoar:2025-02-14T12:55:38Brazilian Journal of Transplantation - Associação Brasileira de Transplante de Órgãos (ABTO)false |
dc.title.none.fl_str_mv |
Late Renal Effects of COVID-19 in Kidney Transplant Recipients: A Single-Center Study Efeitos Renais Tardios de COVID-19 em Receptores de Transplante Renal: Estudo Unicêntrico |
title |
Late Renal Effects of COVID-19 in Kidney Transplant Recipients: A Single-Center Study |
spellingShingle |
Late Renal Effects of COVID-19 in Kidney Transplant Recipients: A Single-Center Study Gomes, Bruno Teixeira Transplante de Rim COVID-19 SARS-CoV-2 Síndrome de COVID-19 Pós-Aguda Proteinúria Kidney transplantation COVID-19 SARS-CoV-2 Post-Acute COVID-19 Syndrome Proteinuria |
title_short |
Late Renal Effects of COVID-19 in Kidney Transplant Recipients: A Single-Center Study |
title_full |
Late Renal Effects of COVID-19 in Kidney Transplant Recipients: A Single-Center Study |
title_fullStr |
Late Renal Effects of COVID-19 in Kidney Transplant Recipients: A Single-Center Study |
title_full_unstemmed |
Late Renal Effects of COVID-19 in Kidney Transplant Recipients: A Single-Center Study |
title_sort |
Late Renal Effects of COVID-19 in Kidney Transplant Recipients: A Single-Center Study |
author |
Gomes, Bruno Teixeira |
author_facet |
Gomes, Bruno Teixeira Sousa, Marcos Vinicius de Bressanin, Fernanda Garcia Rossi, Matheus Rizzato Mazzali, Marilda |
author_role |
author |
author2 |
Sousa, Marcos Vinicius de Bressanin, Fernanda Garcia Rossi, Matheus Rizzato Mazzali, Marilda |
author2_role |
author author author author |
dc.contributor.author.fl_str_mv |
Gomes, Bruno Teixeira Sousa, Marcos Vinicius de Bressanin, Fernanda Garcia Rossi, Matheus Rizzato Mazzali, Marilda |
dc.subject.por.fl_str_mv |
Transplante de Rim COVID-19 SARS-CoV-2 Síndrome de COVID-19 Pós-Aguda Proteinúria Kidney transplantation COVID-19 SARS-CoV-2 Post-Acute COVID-19 Syndrome Proteinuria |
topic |
Transplante de Rim COVID-19 SARS-CoV-2 Síndrome de COVID-19 Pós-Aguda Proteinúria Kidney transplantation COVID-19 SARS-CoV-2 Post-Acute COVID-19 Syndrome Proteinuria |
description |
Introduction: During the coronavirus disease 2019 (COVID-19) pandemic, kidney transplant recipients had higher rates of hospitalization and mortality. However, data on the late renal effects of the infection are scarce. Objectives: This study aims to describe the evolution of renal function and proteinuria in kidney transplant recipients after the infection. Methods: Single-center prospective cohort study. A total of 321 kidney transplant recipients who survived COVID-19 from March 2020 to December 2022 were included. Data on renal function, proteinuria, and immunosuppression were analyzed pre-infection, 3 and 6 months post-infection. Results: Most patients were male (58.9%), with a mean age of 50 years, recipients of kidneys from deceased donors (79.4%), and with a median time after transplant of 6.6 years. There was a reduction in the level of immunosuppression, from a pre-infection Vasudev score of 4.66 to 4.50 (p< 0.001) in the 3rd month and 4.54 (p = 0.016) 6 months post-infection. The glomerular filtration rate (GFR) remained stable at around 60 mL/min/1.73 m2. The percentage of patients with proteinuria ≥ 1.0 increased from 9.6% pre-infection to more than 13% (p < 0.001) in the 3rd and 6th months after infection. Higher proteinuria levels were observed in recipients with longer follow-up post-transplant, previous rejection episodes, lower estimated GFR, and higher prevalence of donor-specific anti-HLA antibodies. Conclusions: Kidney transplant recipients with COVID-19 had an increase in proteinuria within 6 months after the infection despite a stable GFR. |
publishDate |
2025 |
dc.date.none.fl_str_mv |
2025-02-14 |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
https://bjt.emnuvens.com.br/revista/article/view/654 |
url |
https://bjt.emnuvens.com.br/revista/article/view/654 |
dc.language.iso.fl_str_mv |
eng por |
language |
eng por |
dc.relation.none.fl_str_mv |
https://bjt.emnuvens.com.br/revista/article/view/654/727 https://bjt.emnuvens.com.br/revista/article/view/654/728 |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf application/pdf |
dc.publisher.none.fl_str_mv |
Associação Brasileira de Transplante de Órgãos (ABTO) |
publisher.none.fl_str_mv |
Associação Brasileira de Transplante de Órgãos (ABTO) |
dc.source.none.fl_str_mv |
Brazilian Journal of Transplantation; Vol. 28 (2025) Brazilian Journal of Transplantation; v. 28 (2025) 2764-1589 reponame:Brazilian Journal of Transplantation instname:Associação Brasileira de Transplante de Órgãos (ABTO) instacron:ABTO |
instname_str |
Associação Brasileira de Transplante de Órgãos (ABTO) |
instacron_str |
ABTO |
institution |
ABTO |
reponame_str |
Brazilian Journal of Transplantation |
collection |
Brazilian Journal of Transplantation |
repository.name.fl_str_mv |
Brazilian Journal of Transplantation - Associação Brasileira de Transplante de Órgãos (ABTO) |
repository.mail.fl_str_mv |
bjt@abto.org.br |
_version_ |
1836111235729326080 |